You are here: Industry Insights > variant

News List

Vaccine makers could make Omicron-specific booster, says Fauci expresspharma
December 07, 2021
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony Fauci told reporters at a White House briefing.
Omicron May Overcome Prior COVID Infection Drugs
December 06, 2021
People who've already had COVID-19 have a higher risk of reinfection with the Omicron coronavirus variant than with earlier variants, new research shows.
UK study finds mRNA COVID-19 vaccines provide biggest booster impact expresspharma
December 03, 2021
The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's vaccine, while all seven increased immunity when given after two doses of AstraZeneca's vaccine.
UK orders extra 114 million COVID-19 vaccines to combat Omicron PharmaTimes
December 03, 2021
Scientists and health experts have cautioned that the new variant could have the ability to bypass the effectiveness of vaccines that are currently available.
First U.S. Omicron Case Reported in California Drugs
December 02, 2021
The first confirmed U.S. case of the Omicron variant has been reported in California, the U.S. Centers for Disease Control and Prevention announced Wednesday.
Total UK cases of Omicron rise to nine PharmaTimes
December 01, 2021
An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine...
deCODE genetics - New study on inheritance and fetal growth prnasia
July 20, 2021
In a paper published in Nature genetics, Scientists from deCODE genetics, a fully owned subsidiary of Amgen, report sequence variants that associate with birth weight and demonstrate how these variants affect birth weight through both the maternal and ...
Heat-tolerant COVID-19 vaccine from IISc effective against all major SARS-CoV-2 variants: Study expresspharma
July 19, 2021
The research, published in the ACS Infectious Diseases journal on Thursday, showed that vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response in mice.
Research finds mutations aid Epsilon coronavirus variant evade protection from vaccines expresspharma
July 08, 2021
Three mutations in the spike protein of Epsilon variant of SARS-CoV-2 help the virus to evade the protection offered by current vaccines or past COVID-19 infection, according to a study.
AZ doses first participants with COVID-19 variant vaccine pharmatimes
June 29, 2021
AstraZeneca (AZ) has announced that the first participants have been vaccinated as part of a Phase II/III trial testing a new COVID-19 variant vaccine – AZD2816.

Previous page 1 2 3 4 5 6 7 Next page